Page 161 - Let them speak Towards a patient reported outcome measure set for

Establishing the core PRO set
Fitzgerald, J., and L. Gallagher. 2022. Parental stress and adjustment in the context of rare genetic
syndromes: A scoping review. Journal of Intellectual Disabilities, 26, 522–544.
Gargon, E., P. R. Williamson, and B. Young. 2017. Improving core outcome set development:
qualitative interviews with developers provided pointers to inform guidance. Journal of Clinical
Epidemiology, 86, 140–152.
Harman, N. L., I. A. Bruce, J. J. Kirkham, et al. 2015. The importance of integration of stakeholder
views in core outcome set development: otitis media with effusion in children with cleft palate.
PloS One, 10, e0129514.
Henderson, M. L., J. K. Zieba, X. Li, et al. 2024. Gene therapy for genetic syndromes: understanding
the current state to guide future care. BioTech, 13, 1.
Huisman, S., D. Festen, and E. Bakker-van Gijssel. 2024. Healthcare for people with intellectual
disabilities in the Netherlands. Journal of Policy and Practice in Intellectual Disabilities, 21,
e12496.
Katon, W., and P. Ciechanowski. 2002. Impact of major depression on chronic medical illness.
Journal of Psychosomatic Research, 53, 859–863.
Kirkham, J. J., K. Davis, D. G. Altman, et al. 2017. Core outcome Set-STAndards for development:
the COS-STAD recommendations. PLoS Medicine, 14, e1002447.
Kirkham, J. J., S. Gorst, D. G. Altman, et al. 2016. Core outcome set–STAndards for reporting: the
COS-STAR statement. PLoS Medicine, 13, e1002148.
Lubbers, K., E. M. Stijl, B. Dierckx, et al. 2022. Autism symptoms in children and young adults with
fragile x syndrome, angelman syndrome, tuberous sclerosis complex, and neurofibromatosis
type 1: a cross-syndrome comparison. Frontiers in Psychiatry, 13, 852208.
Luo, C., W.-R. Ye, W. Shi, et al. 2022. Perfect match: mTOR inhibitors and tuberous sclerosis
complex. Orphanet Journal of Rare Diseases, 17, 106.
Maeder, J., V. Mancini, C. Sandini, et al. 2022. Selective effects of methylphenidate on attention and
inhibition in 22q11. 2 deletion syndrome: results from a clinical trial. International Journal of
Neuropsychopharmacology, 25, 215–225.
Maia, N., M. J. Nabais Sá, M. Melo-Pires, A. P. de Brouwer, and P. Jorge. 2021. Intellectual disability
genomics: current state, pitfalls and future challenges. BMC Genomics, 22, 1–17.
Maulik, P. K., M. N. Mascarenhas, C. D. Mathers, T. Dua, and S.Saxena. 2011. Prevalence of
intellectual disability: a meta-analysis of population-based studies. Research in Developmental
Disabilities, 32, 419–436.
Mishra, S., and M. Venkatesh. 2024. Rare disease clinical trials in the European Union: navigating
regulatory and clinical challenges. Orphanet Journal of Rare Diseases, 19, 285.
Mokkink, L. B., M. Boers, C. van der Vleuten, et al. 2020. COSMIN Risk of Bias tool to assess the
quality of studies on reliability or measurement error of outcome measurement instruments:
a Delphi study. BMC Medical Research Methodology, 20, 1–13.
Müller, A., B. Den Hollander, P. van de Ven, et al. 2024. Cannabidiol (Epidyolex®) for severe behavioral
manifestations in patients with tuberous sclerosis complex, mucopolysaccharidosis type III
and fragile X syndrome: protocol for a series of randomized, placebo-controlled N-of-1 trials.
BMC psychiatry, 24, 23.
Müller, A. R., N. Y. van Silfhout, B. Den Hollander, et al. 2024. Navigating the outcome maze: a scoping
review of outcomes and instruments in clinical trials in genetic neurodevelopmental disorders
and intellectual disability. Therapeutic Advances in Rare Disease, 5, 26330040241245721.
Oude Voshaar, M., C. B. Terwee, L. Haverman, et al. 2023. Development of a standard set of PROs
and generic PROMs for Dutch medical specialist care: Recommendations from the Outcome-
Based Healthcare Program Working Group Generic PROMs. Quality of Life Research, 1595–
1605.
Palmieri, M., D. Pozzer, and N. Landsberger. 2023. Advanced genetic therapies for the treatment
of Rett syndrome: state of the art and future perspectives. Frontiers in Neuroscience, 17,
1172805.
Pouls, K. P., M. Cuypers, M. Mastebroek, et al. 2023. Mental healthcare for adults with mild
intellectual disabilities: population-based database study in Dutch mental health services.
BJPsych Open, 9, e48.
6
159